← All trials
NCT05159388
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 8, 2021
- Primary completion
- Nov 15, 2024
- Completion date
- Nov 15, 2024
- First posted
- Dec 16, 2021
- Last posted
- Dec 16, 2021
- Enrollment
- 45
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pieris Pharmaceuticals GmbHLead sponsor
- Pieris Pharmaceuticals GmbHStudy director
- ServierCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.